# Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)

> **NCT03909750** · PHASE1 · SUSPENDED · sponsor: **Healeon Medical Inc** · enrollment: 50 (estimated)

## Conditions studied

- COPD
- Respiratory Insufficiency

## Interventions

- **PROCEDURE:** Lipoaspiration
- **PROCEDURE:** AD-cSVF
- **PROCEDURE:** Normal Saline IV

## Key facts

- **NCT ID:** NCT03909750
- **Lead sponsor:** Healeon Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-04-10
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909750, "Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD)". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT03909750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*